Modafinil for Treatment of Residual Excessive Sleepiness in Nasal Continuous Positive Airway Pressure-Treated Obstructive Sleep Apnea/Hypopnea Syndrome | Zendy

Jed Black | Zendy; Max Hirshkowitz | Zendy

Open Access

Modafinil for Treatment of Residual Excessive Sleepiness in Nasal Continuous Positive Airway Pressure-Treated Obstructive Sleep Apnea/Hypopnea Syndrome

Author(s) -

Jed Black,

Max Hirshkowitz

Publication year - 2005

Publication title -

sleep

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.222

H-Index - 207

eISSN - 1550-9109

pISSN - 0161-8105

DOI - 10.1093/sleep/28.4.464

Subject(s) - continuous positive airway pressure , modafinil , obstructive sleep apnea , hypopnea , medicine , anesthesia , epworth sleepiness scale , apnea , somnolence , sleep apnea , excessive daytime sleepiness , polysomnography , sleep disorder , insomnia , adverse effect , psychiatry

Nasal continuous positive airway pressure (nCPAP) usually reduces sleepiness in patients with obstructive sleep apnea/hypopnea syndrome. However, even with regular use of nCPAP, some patients experience residual excessive sleepiness. We evaluated the efficacy and safety of the wake-promoting agent modafinil for treating residual excessive sleepiness in nCPAP-treated patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research